892 related articles for article (PubMed ID: 27995598)
1. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
[TBL] [Abstract][Full Text] [Related]
2. Predicting IVIG resistance in UK Kawasaki disease.
Davies S; Sutton N; Blackstock S; Gormley S; Hoggart CJ; Levin M; Herberg JA
Arch Dis Child; 2015 Apr; 100(4):366-8. PubMed ID: 25670405
[TBL] [Abstract][Full Text] [Related]
3. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
Fabi M; Andreozzi L; Corinaldesi E; Bodnar T; Lami F; Cicero C; Tchana B; Landini C; Sprocati M; Bigucci B; Balsamo C; Sogno Valin P; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
Eur J Pediatr; 2019 Mar; 178(3):315-322. PubMed ID: 30499051
[TBL] [Abstract][Full Text] [Related]
4. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
5. Verification of risk scores to predict i.v. immunoglobulin resistance in incomplete Kawasaki disease.
Kanamitsu K; Kakimoto H; Shimada A; Nakata Y; Ochi H; Watanabe H; Iwasaki Y; Tokorodani C; Kanazawa A; Maruyama H; Miyazawa M; Nishiuchi R; Kikkawa K
Pediatr Int; 2016 Feb; 58(2):146-51. PubMed ID: 26190225
[TBL] [Abstract][Full Text] [Related]
6. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM; Silverman ED; McCrindle BW; Yeung RS
J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
[TBL] [Abstract][Full Text] [Related]
7. Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.
Tajima M; Shiozawa Y; Kagawa J
Pediatr Cardiol; 2015 Aug; 36(6):1159-65. PubMed ID: 25753685
[TBL] [Abstract][Full Text] [Related]
8. The factors affecting the disease course in Kawasaki disease.
Arslanoglu Aydin E; Ertugrul I; Bilginer Y; Batu ED; Sonmez HE; Demir S; Arici ZS; Sag E; Alehan D; Ozen S
Rheumatol Int; 2019 Aug; 39(8):1343-1349. PubMed ID: 31139951
[TBL] [Abstract][Full Text] [Related]
9. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
10. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.
Fabi M; Andreozzi L; Frabboni I; Dormi A; Corinaldesi E; Lami F; Cicero C; Tchana B; Francavilla R; Sprocati M; Bigucci B; Balsamo C; Valin PS; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
Clin Rheumatol; 2021 Apr; 40(4):1507-1514. PubMed ID: 32936425
[TBL] [Abstract][Full Text] [Related]
11. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.
Downie ML; Manlhiot C; Collins TH; Chahal N; Yeung RSM; McCrindle BW
Int J Cardiol; 2017 Jun; 236():157-161. PubMed ID: 28089146
[TBL] [Abstract][Full Text] [Related]
13. High neutrophil : lymphocyte ratio is associated with refractory Kawasaki disease.
Cho HJ; Bak SY; Kim SY; Yoo R; Baek HS; Yang S; Hwang IT; Ban JE
Pediatr Int; 2017 Jun; 59(6):669-674. PubMed ID: 28097746
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Coronary Artery Aneurysm in a Chinese Pediatric Population with Kawasaki Disease at Low Risk of Intravenous Immunoglobulin Resistance: A Retrospective Cohort Study.
Liu J; Su D; Yuan P; Ye B; Qin S; Pang Y
Cardiology; 2023; 148(5):457-468. PubMed ID: 37231847
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
[TBL] [Abstract][Full Text] [Related]
16. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
[TBL] [Abstract][Full Text] [Related]
17. Japanese Kawasaki Disease Scoring Systems: Are they Applicable to the Iranian Population?
Edraki MR; Mohammadi H; Mehdizadegan N; Ghorashi M; Amoozgar H; Borzouee M; Ajami G; Keshavarz K; Dehghani E; Bahrami R
Arch Iran Med; 2020 Jan; 23(1):31-36. PubMed ID: 31910632
[TBL] [Abstract][Full Text] [Related]
18. Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different Ethnicities.
Loomba RS; Raskin A; Gudausky TM; Kirkpatrick E
Am J Ther; 2016; 23(6):e1293-e1299. PubMed ID: 25611359
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors for coronary artery lesions in children with Kawasaki disease].
Li Y; Wang XM; Liu YL; Shi K; Yang YF; Guo YH
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):938-41. PubMed ID: 23234782
[TBL] [Abstract][Full Text] [Related]
20. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
Friedman KG; Gauvreau K; Hamaoka-Okamoto A; Tang A; Berry E; Tremoulet AH; Mahavadi VS; Baker A; deFerranti SD; Fulton DR; Burns JC; Newburger JW
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
